Dr. Ünal Metin Tokat

Precision Oncology Scientist (PhD)
Molecular Biologist & Geneticist

He performs in-depth analysis of comprehensive genomic profiling (CGP) data to identify targetable mutations and biomarkers, and designs patient-specific treatment plans through CGP curation reports that integrate clinical and molecular data. To share innovative applications and complex cases with the scientific community and the public, he prepares peer-reviewed articles and case studies; and by designing and running educational workshops and mentorship (preceptorship) programs for healthcare professionals, he advances his expertise in precision oncology.

Professional career

2026 – Present

Clinical Cancer & Precision Oncology Specialist

MDT Molecular Decision Technologies Inc.

2022 – Present

Clinical Cancer & Precision Oncology Specialist

Medicana Health Group, Personalized Cancer Treatment Center

2022 – 2025

Clinical Cancer & Precision Oncology Specialist

Demiray Health Services Trade Ltd.

2018 – 2022

Graduate Researcher & Laboratory Assistant

İhsan Doğramacı Bilkent University, Department of Molecular Biology and Genetics

Academic career

2015 – 2022

Integrated PhD · Engineering and Science (High Honors, TÜBİTAK BİDEB 2211/A PhD Scholar)

İhsan Doğramacı Bilkent University

2010 – 2015

BSc · Molecular Biology and Genetics (4th in department, High Honors)

İhsan Doğramacı Bilkent University

Areas of work

Designing Personalized Treatment Plans

Through Molecular Tumor Board (MTB) participation and curation reports, designing personalized treatment options by jointly analyzing comprehensive genomic profiling and other data types together with the scientific literature, following treatment responses, and steering the process accordingly.

Scientific Project Design and Leadership

Generating scientific project ideas and preliminary data, preparing project documentation, and — after assembling clinical data — running projects through literature review and data analysis.

Scientific Publications

Preparing publications focused on precision oncology, cancer genomics and biology, drug resistance mechanisms, and disease monitoring.

Training Programs

Designing the scope and content of, and delivering, precision oncology training programs for medical oncologists and other clinical professionals.

Scientific publications

Articles published in international peer-reviewed journals, citations, and the latest academic record can be accessed via the link below.

International network

For multidisciplinary projects in precision oncology, Molecular Tumor Board (MTB) partnerships, and professional contact, you can connect via the LinkedIn profile.